{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-020822","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2023-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.900214+00:00","generated_at":"2026-06-14T02:52:33.740900+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bioxytran secures $500k equity investment from Triton Funds for COVID-19 trial funding","bullets":["Triton Funds LP to purchase 1,612,903 shares at $0.31/share, totaling $500,000.","Proceeds will fund dosage optimization study for mild-moderate COVID-19; dosing expected within month.","Funding sufficient to reach Phase 3 regulatory submission milestone in India.","Triton is second institutional investor alongside Walleye Capital (over $5B AUM).","Company also amended WallachBeth engagement for brokerage of notes totaling $1.165M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-020822","json":"https://secwatch.observer/filing/0001493152-23-020822.json","markdown":"https://secwatch.observer/filing/0001493152-23-020822.md","text":"https://secwatch.observer/filing/0001493152-23-020822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315223020822/0001493152-23-020822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315223020822/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T02:52:33.740900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f360db02b4ae17b71c30bc9782424e82f763b7e","claim":"BIOXYTRAN, INC entered into Common Stock Closing Agreement with Triton Funds LP valued at Purchase of 1,612,903 shares for $500,000 (approx. $0.31 per share) (effective 2023-06-08).","evidence_excerpt":"On June 8, 2023, Bioxytran, Inc. (the “Company”) entered into a common stock closing agreement (the “Closing Agreement”) with Triton Funds LP (“Triton”). Pursuant to the Closing Agreement, subject to certain conditions set forth in the Closing Agreement, Triton will purchase one million six hundred twelve thousand nine hundred three (1,612,903) shares of the Company’s Common Stock for an amount of five hundred thousand dollars ($500,000), or $0.31 per share (the “Closing Price”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445815/000149315223020822/0001493152-23-020822-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Triton Funds LP"},{"label":"Value","value":"Purchase of 1,612,903 shares for $500,000 (approx. $0.31 per share)"},{"label":"Effective","value":"2023-06-08"}],"fact_type":"material_agreement"},{"claim_id":"b5533c106fe949f457e9ea368a3bdede7e2da7f1","claim":"BIOXYTRAN, INC entered into Amended Engagement Letter with WallachBeth Capital LLC valued at Brokerage of three notes totaling $1,165,000, with issuance of 800,000 warrants exercisable at $0.20 (effective 2023-05-08).","evidence_excerpt":"On May 8, 2023, Bioxytran, Inc. (the “Company”) signed an amended engagement letter (the “Engagement Agreement”) with WallachBeth Capital LLC (“WallachBeth”) to brokerage a deal for three (3) of Company’s outstanding Notes, for a total value of one million one hundred sixty-five thousand dollars ($1,165,000).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445815/000149315223020822/0001493152-23-020822-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"WallachBeth Capital LLC"},{"label":"Value","value":"Brokerage of three notes totaling $1,165,000, with issuance of 800,000 warrants exercisable at $0.20"},{"label":"Effective","value":"2023-05-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}